ODT
Vanguard Group’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-964,818
| Closed | -$1.3M | – | 4686 |
|
|
2021
Q4 | $1.3M | Buy |
964,818
+2,619
| +0.3% | +$3.53K | ﹤0.01% | 4185 |
|
|
2021
Q3 | $2.8M | Sell |
962,199
-6,488
| -0.7% | -$18.9K | ﹤0.01% | 3944 |
|
|
2021
Q2 | $3.38M | Buy |
968,687
+10,100
| +1% | +$35.3K | ﹤0.01% | 3784 |
|
|
2021
Q1 | $3.28M | Sell |
958,587
-10,120
| -1% | -$34.6K | ﹤0.01% | 3725 |
|
|
2020
Q4 | $18.6M | Buy |
968,707
+198,536
| +26% | +$3.81M | ﹤0.01% | 2671 |
|
|
2020
Q3 | $10.3M | Buy |
770,171
+88,100
| +13% | +$1.18M | ﹤0.01% | 2769 |
|
|
2020
Q2 | $28.9M | Buy |
682,071
+15,732
| +2% | +$666K | ﹤0.01% | 2255 |
|
|
2020
Q1 | $18.4M | Sell |
666,339
-8,755
| -1% | -$242K | ﹤0.01% | 2331 |
|
|
2019
Q4 | $21.9M | Buy |
675,094
+2,419
| +0.4% | +$78.5K | ﹤0.01% | 2493 |
|
|
2019
Q3 | $17.5M | Buy |
672,675
+225,264
| +50% | +$5.86M | ﹤0.01% | 2553 |
|
|
2019
Q2 | $16.4M | Buy |
447,411
+85,133
| +23% | +$3.12M | ﹤0.01% | 2610 |
|
|
2019
Q1 | $8.01M | Buy |
362,278
+144,148
| +66% | +$3.19M | ﹤0.01% | 2940 |
|
|
2018
Q4 | $3.07M | Sell |
218,130
-98,603
| -31% | -$1.39M | ﹤0.01% | 3252 |
|
|
2018
Q3 | $6.15M | Buy |
316,733
+49,528
| +19% | +$961K | ﹤0.01% | 3153 |
|
|
2018
Q2 | $5.9M | Buy |
267,205
+20,008
| +8% | +$442K | ﹤0.01% | 3151 |
|
|
2018
Q1 | $5.24M | Buy |
247,197
+186,767
| +309% | +$3.96M | ﹤0.01% | 3134 |
|
|
2017
Q4 | $1.51M | Buy |
+60,430
| New | +$1.51M | ﹤0.01% | 3506 |
|